Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Gets More Time for Nasdaq Compliance

NEW YORK (GenomeWeb News) – Nanogen said in a filing with the US Securities and Exchange Commission today that it now has until May 27 to regain compliance with Nasdaq's $1 minimum bid price listing requirement.

Nanogen was notified in May 2008 that it was not in compliance with the minimum bid rule, and the firm had until the end of November to regain compliance. However, in October, due to the suspension by Nasdaq of certain listing requirements, Nanogen was given until Feb. 26 to regain compliance.

On Dec. 19, 2008, Nasdaq extended the temporary suspension of the minimum bid price requirement until April 20, 2009, on which date the rules will be reinstated. This extension means that Nanogen will now have until May 27 to regain compliance. The firm's share price must close at $1 for a minimum of 10 consecutive trading days for it to meet listing requirements.

Nanogen closed Tuesday at $.18 per share. Its shares have not traded above $1 since Oct. 30, 2007.

Filed under

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.